Literature DB >> 14582706

Beta-chemokine, macrophage inflammatory protein-1beta (MIP-1beta), is highly expressed in diffuse type human gastric cancers.

S Saito1, J Kitayama, Z X Jin, N Tsuno, S Kaisaki, Y Seto, H Nagawa.   

Abstract

Chemokines have been shown to be expressed in some malignant or precancerous tissues. However, the role of these chemokines on tumor development or progression is not clear. The expression patterns of chemokines in gastric cancer tissues were examined in 86 surgically resected samples using immunohistochemistry. Macrophage inflammatory protein-1beta (MIP-1beta) was clearly detected in many gastric carcinoma cells. In most of the differentiated carcinomas, intracellular localization of MIP-1beta was detected in more than 5% of cancer cells, although the percentages of MIP-1beta-positive cells differed among each sample. Undifferentiated carcinomas showed contrasted staining pattern between solid type and non-solid (diffuse) type. MIP-1beta was totally absent in all the poorly differentiated carcinomas with solid type growth pattern (por1). In contrast, MIP-1beta was highly expressed in all of the non-solid type of poorly differentiated carcinoma (por2) and signet-ring cell carcinoma samples. In particular, MIP-1beta was strongly stained in carcinoma cells at the front of invasive lesions. In 43 diffuse type undifferentiated cancers, tumors with high expression of MIP-1beta exhibited significantly more lymph node metastasis. Our results suggest a possibility that MIP-1beta may be related to the scattering and invasion step of gastric carcinoma cells with undifferentiated phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14582706

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  7 in total

1.  Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells.

Authors:  Melanie Mestdagt; Myriam Polette; Giovanna Buttice; Agnes Noël; Atsuhisa Ueda; Jean-Michel Foidart; Christine Gilles
Journal:  Int J Cancer       Date:  2006-01-01       Impact factor: 7.396

2.  Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer.

Authors:  Levar Shamoun; Kalle Landerholm; Amanda Balboa Ramilo; Roland E Andersson; Jan Dimberg; Dick Wågsäter
Journal:  World J Gastroenterol       Date:  2021-08-14       Impact factor: 5.742

3.  Identification and validation of genes involved in gastric tumorigenesis.

Authors:  Neelakantan Vijayalakshmi; Gopisetty Gopal; Thangarajan Rajkumar; Kesavan Sabitha; Sundersingh Shirley; Uthandaraman M Raja; Seshadri A Ramakrishnan
Journal:  Cancer Cell Int       Date:  2010-11-24       Impact factor: 5.722

4.  Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.

Authors:  M Sadeghi; I Lahdou; H Oweira; V Daniel; P Terness; J Schmidt; K-H Weiss; T Longerich; P Schemmer; G Opelz; A Mehrabi
Journal:  Br J Cancer       Date:  2015-08-13       Impact factor: 7.640

5.  Elevated level of some chemokines in plasma of gastric cancer patients.

Authors:  Monika Baj-Krzyworzeka; Kazimierz Węglarczyk; Jarek Baran; Antoni Szczepanik; Mirosław Szura; Maciej Siedlar
Journal:  Cent Eur J Immunol       Date:  2017-01-24       Impact factor: 2.085

6.  Impact of CCL4 gene polymorphisms and environmental factors on oral cancer development and clinical characteristics.

Authors:  Ming-Yu Lien; Chiao-Wen Lin; Hsiao-Chi Tsai; Yng-Tay Chen; Ming-Hsui Tsai; Chun-Hung Hua; Shun-Fa Yang; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2017-05-09

Review 7.  Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.

Authors:  Sha-Sha Wang; Xiao Cen; Xin-Hua Liang; Ya-Ling Tang
Journal:  Oncotarget       Date:  2017-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.